Biohaven (BHVN) Total Liabilities (2021 - 2026)
Biohaven (BHVN) reported Total Liabilities of $336.9 million for Q1 2026, up 68.92% on a YoY basis from $199.5 million in Q1 2025, and down 15.64% sequentially from $399.4 million in Q4 2025.
Biohaven (BHVN) Total Liabilities (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Total Liabilities data on file, last reported at $336.9 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 68.92% year-over-year to $336.9 million; the trailing twelve-month figure through Mar 2026 stood at $336.9 million (up 68.92% YoY), and the FY2025 full-year result was $399.4 million, up 108.36% from the prior year.
- Total Liabilities fell to $336.9 million in Q1 2026, from $399.4 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $426.3 million in Q3 2025 to a low of $35.4 million in Q3 2022.
- A 5-year average of $205.5 million and a median of $191.7 million in 2024 frame the typical range for Total Liabilities.
- Peak annual rise in Total Liabilities reached 161.73% in 2023, while the deepest fall reached 30.71% in 2023.
- Tracing BHVN's Total Liabilities over 5 years: stood at $123.0 million in 2022, then slumped by 30.71% to $85.2 million in 2023, then soared by 124.87% to $191.7 million in 2024, then jumped by 108.36% to $399.4 million in 2025, then slipped by 15.64% to $336.9 million in 2026.
- Business Quant data shows BHVN's Total Liabilities at $336.9 million in Q1 2026, $399.4 million in Q4 2025, and $426.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | 336.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 336.91 Mn |
| Dec 31, 2025 | 399.38 Mn |
| Sep 30, 2025 | 426.28 Mn |
| Jun 30, 2025 | 415.83 Mn |
| Mar 31, 2025 | 199.45 Mn |
| Dec 31, 2024 | 191.67 Mn |
| Sep 30, 2024 | 194.52 Mn |
| Jun 30, 2024 | 198.90 Mn |
| Mar 31, 2024 | 117.09 Mn |
| Dec 31, 2023 | 85.24 Mn |
| Sep 30, 2023 | 92.73 Mn |
| Jun 30, 2023 | 119.48 Mn |
| Mar 31, 2023 | 146.26 Mn |
| Dec 31, 2022 | 123.01 Mn |
| Sep 30, 2022 | 35.43 Mn |
| Dec 31, 2021 | 47.37 Mn |